Aurinia Pharmaceuticals Inc.

(AUP:PUR)

By |

Profile

Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The firm is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.

Contact Information

Website: www.auriniapharma.com
Email: ir@auriniapharma.com
Main Phone: +1 250 744-2487
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CAN
Postal Code: V8Z 7X8

Issuer Information

Exchange: TSX
CEO: Richard M. Glickman
Employees: 33
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 7.52 $ 0. (0.00%)
Last Price 7.52 Change $ 0. Change % 0.00 Tick N/A
Bid 7.52 Bid Size 100.00 Ask 7.59 Ask Size 800.00
Open N/A High N/A Low N/A Prev Close 7.52
Last Trade Volume 0 52 Wk Hi 9.05 52 Wk Low 5.95
Market Cap 635.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 84,478,054.00 EPS (TTM) -1.20 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20.94 20.94 20.94 20.94
Low Target Price Estimate 12.8 12.8 12.8 12.8
Mean Target Price Estimate 16.27 16.27 16.27 16.27
Standard Deviation 3.2 3.2 3.2 3.2
Date of Most Recent Estimate 05/11/18 05/11/18 05/11/18 06/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.41 1.41 1.41 1.41